AT-08 RADIOTHERAPY WITH VS WITHOUT TEMOZOLOMIDE IN OLDER PATIENTS WITH GLIOBLASTOMA

BACKGROUND: A randomized trial of glioblastoma patients aged ≤70 years demonstrated that adding temozolomide (TMZ) to radiotherapy (RT) improved overall survival (OS). We examined whether adding TMZ to RT was associated with improved OS in older glioblastoma patients. METHODS: We performed a retrosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Arvold, Nils, Cefalu, Matthew, Wang, Yun, Zigler, Cory, Schrag, Deborah, Dominici, Francesca
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217845/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars